CTRI/2023/01/048894尚未招募未知
To Study the changes in Lipid Profile in patients with Cirrhosis of Liver : An observational prospective study in a tertiary care teaching hospital.
PCMC PGI YCM Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •liver cirrhosis patients were taken as Group A and apparently healthy age- and sex-matched patients as Group B.
排除标准
- •The patients were cholesterol-lowering medicines within the previous 30 days. Patients with a history of other medical illnesses which may influence the serum lipid level such as diabetes mellitus, hypertension, chronic smoker, nephrotic syndrome, and/or thyroid dysfunctions were excluded from the study from both Group A and Group B.
- •All patients who have refused to give consent for the study
研究者
相似试验
进行中（未招募）
1 期
Characterization of lipid changes in patients with ulcerative colitis treated with tofactinib or infliximabEUCTR2018-004587-61-NLErasmus Medical Center40
尚未招募
不适用
ipid changes in patients with active ulcerative colitis treated with either tofacitinib or infliximabNL-OMON23533Erasmus Medical Center40
已完成
4 期
Deep profiling of lipid changes in patients with active ulcerative colitis treated with either tofacitinib or infliximabulcerative colitisinflammatory bowel disease1001796910003816NL-OMON55536Erasmus MC, Universitair Medisch Centrum Rotterdam40
已完成
4 期
BASIC: Boosted Atazanavir or Saquinavir Induced Lipid ChangesHIV InfectionsNCT00389402International Antiviral Therapy Evaluation Center120
进行中（未招募）
1 期
Outcome of plasma lipid profile in patients switching from Atripla® to Eviplera® compared to continuing on Atripla® (EfaRiLipidomics)EUCTR2015-002319-13-ESFundació Hospital Vall Hebron Institut de Recerca